rs140557878
Positions:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_173728.4(ARHGEF15):āc.2442A>Gā(p.Glu814=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,613,912 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00019 ( 0 hom., cov: 31)
Exomes š: 0.00019 ( 1 hom. )
Consequence
ARHGEF15
NM_173728.4 synonymous
NM_173728.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.258
Genes affected
ARHGEF15 (HGNC:15590): (Rho guanine nucleotide exchange factor 15) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein-coupled receptors. This gene encodes a protein that functions as a specific guanine nucleotide exchange factor for RhoA. It also interacts with ephrin A4 in vascular smooth muscle cells. Two alternatively spliced transcripts variants that encode the same protein have been found for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 17-8320909-A-G is Benign according to our data. Variant chr17-8320909-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 242020.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.258 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF15 | NM_173728.4 | c.2442A>G | p.Glu814= | synonymous_variant | 16/16 | ENST00000361926.8 | NP_776089.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF15 | ENST00000361926.8 | c.2442A>G | p.Glu814= | synonymous_variant | 16/16 | 1 | NM_173728.4 | ENSP00000355026 | P1 | |
ARHGEF15 | ENST00000421050.2 | c.2442A>G | p.Glu814= | synonymous_variant | 16/16 | 1 | ENSP00000412505 | P1 | ||
ARHGEF15 | ENST00000647883.1 | c.1905A>G | p.Glu635= | synonymous_variant | 13/13 | ENSP00000498197 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152116Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
29
AN:
152116
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000235 AC: 59AN: 251456Hom.: 1 AF XY: 0.000258 AC XY: 35AN XY: 135916
GnomAD3 exomes
AF:
AC:
59
AN:
251456
Hom.:
AF XY:
AC XY:
35
AN XY:
135916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000194 AC: 283AN: 1461796Hom.: 1 Cov.: 53 AF XY: 0.000216 AC XY: 157AN XY: 727184
GnomAD4 exome
AF:
AC:
283
AN:
1461796
Hom.:
Cov.:
53
AF XY:
AC XY:
157
AN XY:
727184
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000191 AC: 29AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.000256 AC XY: 19AN XY: 74304
GnomAD4 genome
AF:
AC:
29
AN:
152116
Hom.:
Cov.:
31
AF XY:
AC XY:
19
AN XY:
74304
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at